Basic Policy Examples of working on the creation of pharmaceuticals ...
At the EHS Committee consisting with members of production sites, researc...
Concerning emissions from our company (Scope 1+2) since FY2019, ONO ha...
As for water risks, the Environmental Management Committee and the Water ...
Since the misconduct that occurred in FY2020 (hereinafter referred to as ...
We commit to contributing to sustainable social development as well as to...
We implement all the principles of the Corporate Governance Code stipulat...
Promoting Appointment of Young, Mid-Career, and Female Employees Acqui...
We have been holding ESG presentation Meeting every year since March 2...
Sustainability Report 2023 Sustainability Report 2023 Susta...
Growth Strategy and Talent Strategy Towards Achievement of Corporate Phi...
Information Disclosure IR Activities ESG Activities
We conduct environmental efficiency assessments to quantitatively measure t...
External evaluation of ESG (Environmental, Social and Governance) ...
We have established an internal system in accordance with the basic views...
ONO Pharmaceutical’s Compliance System Initiatives to Strengthen Comp...
Handling of the active pharmaceutical ingredient (API) and environmental ...
The talents we desire are motivated, proactive, self-disciplined, indep...
Analysis and Evaluation of Risks and Opportunities related to Climate Ch...
The total volume of our industrial waste in FY2022 increased by 13.1 tons...
Through content and applications, the latest information useful for healt...
Our Materiality Steps in materiality analysis Actions for Materialit...
